KELLY JOYNER: Open Payments
NPI 1184397291 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 51 payments from 16 companies in 2025. Trend: 2023 $530 · 2024 $1,266 · 2025 $980
Food & beverage: $980
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $221 |
| E.R. Squibb & Sons, L.L.C. | 13 | $172 |
| Amgen Inc. | 3 | $83 |
| HEARTFLOW, INC. | 3 | $80 |
| PFIZER INC. | 3 | $62 |
| Novo Nordisk Inc | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| SCPHARMACEUTICALS INC. | 2 | $35 |
Products named: LEQVIO, CAMZYOS, REPATHA, FFRct, VYNDAQEL, FARXIGA, ELIQUIS, JARDIANCE.
Industry payments across CO — which companies pay providers there.
